Literature DB >> 26767839

Holoprosencephaly: antenatal and postnatal diagnosis and outcome.

Chandrasekaran Kaliaperumal1, Sam Ndoro2, Tafadzwa Mandiwanza1, F Reidy3,4, F McAuliffe3,4, John Caird1, Darach Crimmins1.   

Abstract

OBJECTIVES: The objectives of this study are to ascertain the clinical outcome and overall survival of holoprosencephaly (HPE) patients diagnosed antenatally and postnatally, to determine the accuracy of antenatal diagnosis and to determine the role of neurosurgical intervention in HPE.
DESIGN: This is a retrospective review over a 10-year period. PATIENTS: Sixty-three patients were included in the study, 45 were diagnosed by antenatal radiological imaging and 18 were diagnosed by postnatal radiological imaging. Patient data was drawn from Temple Street Children's University Hospital (the national paediatric neurosurgery centre), the National Maternity Hospital in Holle's Street, Dublin, and Our Lady of Sick Children Hospital, Dublin.
METHODS: The study was carried out through a review of antenatal and postnatal radiological imaging and reports, clinical charts, GP letters from patient follow-up and telephone conversations with parents of HPE patients.
RESULTS: Four patients in the antenatal diagnosis group had follow-up foetal MRI confirming HPE. Twelve in this group had radiological follow-up postnatally, and in five of these, HPE was confirmed. The remaining seven were identified as false positive. Alobar HPE constituted 55 % (21/38) of patients with 95 % mortality. Fifty-one percent had a normal karyotype. The overall survival in the antenatal diagnosis group was 13 %. In the postnatal group, 18 patients were identified, 67 % (12/18) lobar and 33 % (6/18) semilobar. Normal karyotype was found in 72 % (13/18), with an overall survival rate of 56 % (10/18). Neurosurgical intervention in both groups mainly consisted of CSF diversion in the form of ventriculoperitoneal (VP) or cystoperitoneal shunt (CP) (13/67).
CONCLUSION: Foetal MRI should be routinely performed in suspected cases of HPE, and reliance on ultrasound alone in the antenatal period may not be sufficient. In our study, there is a high early mortality noted in severe cases of HPE, while milder forms of HPE in children tend to survive beyond infancy albeit with associated complications that required neurosurgical intervention and medical management for other associated systemic anomalies.

Entities:  

Keywords:  Antenatal; Holoprosencephaly; Magnetic resonance imaging; Postnatal

Mesh:

Year:  2016        PMID: 26767839     DOI: 10.1007/s00381-016-3015-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  35 in total

1.  First-trimester sonographic diagnosis of holoprosencephaly: value of the "butterfly" sign.

Authors:  Waldo Sepulveda; Victor Dezerega; Cecilia Be
Journal:  J Ultrasound Med       Date:  2004-06       Impact factor: 2.153

2.  Central nervous system and limb anomalies in case reports of first-trimester statin exposure.

Authors:  Robin J Edison; Maximilian Muenke
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

3.  New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases.

Authors:  Sandra Mercier; Christèle Dubourg; Nicolas Garcelon; Boris Campillo-Gimenez; Isabelle Gicquel; Marion Belleguic; Leslie Ratié; Laurent Pasquier; Philippe Loget; Claude Bendavid; Sylvie Jaillard; Lucie Rochard; Chloé Quélin; Valérie Dupé; Véronique David; Sylvie Odent
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

Review 4.  Magnetic resonance imaging of normal and abnormal brain development.

Authors:  A J Barkovich; T V Maroldo
Journal:  Top Magn Reson Imaging       Date:  1993

5.  Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984-1989.

Authors:  C L Olsen; J P Hughes; L G Youngblood; M Sharpe-Stimac
Journal:  Am J Med Genet       Date:  1997-12-12

6.  Descriptive epidemiology of holoprosencephaly and arhinencephaly in metropolitan Atlanta, 1968-1992.

Authors:  S A Rasmussen; C A Moore; M J Khoury; J F Cordero
Journal:  Am J Med Genet       Date:  1996-12-18

7.  Holoprosencephaly in the west of Scotland 1975-1994.

Authors:  M L Whiteford; J L Tolmie
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

8.  A retrospective survey of perinatal risk factors of 104 living children with holoprosencephaly.

Authors:  Elaine E Stashinko; Nancy J Clegg; Heather A Kammann; Vicki T Sweet; Mauricio R Delgado; Jin S Hahn; Eric B Levey
Journal:  Am J Med Genet A       Date:  2004-07-15       Impact factor: 2.802

Review 9.  Management of children with holoprosencephaly.

Authors:  Eric B Levey; Elaine Stashinko; Nancy J Clegg; Mauricio R Delgado
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 10.  Neuroimaging advances in holoprosencephaly: Refining the spectrum of the midline malformation.

Authors:  Jin S Hahn; Patrick D Barnes
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

View more
  1 in total

1.  Survival of children with rare structural congenital anomalies: a multi-registry cohort study.

Authors:  Alessio Coi; Michele Santoro; Anna Pierini; Judith Rankin; Svetlana V Glinianaia; Joachim Tan; Abigail-Kate Reid; Ester Garne; Maria Loane; Joanne Given; Elisa Ballardini; Clara Cavero-Carbonell; Hermien E K de Walle; Miriam Gatt; Laura García-Villodre; Mika Gissler; Sue Jordan; Sonja Kiuru-Kuhlefelt; Stine Kjaer Urhoj; Kari Klungsøyr; Nathalie Lelong; L Renée Lutke; Amanda J Neville; Makan Rahshenas; Ieuan Scanlon; Diana Wellesley; Joan K Morris
Journal:  Orphanet J Rare Dis       Date:  2022-03-29       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.